证券代码：301092 证券简称：争光股份 浙江争光实业股份有限公司 投资者关系活动记录表 编号：2022-002 | --- | --- | --- | |----------------|------------------------------|------------------------------------------------------| | | | | | 投资者关系活动 | 特定对象调研 | □分析师会议 | | 类别 | □媒体采访 □业绩说明会 | | | | □新闻发布会 □路演活动 | | | | 现场参观 | | | | □其他 | （请文字说明其他活动内容） | | 参与单位名称及 | 宝盈基金管理有限公司 | 朱建明、 | | 人员姓名 | 国联证券股份有限公司 | 吴杨、 | | | 东吴证券股份有限公司 | 叶灵巧、 | | | 浙江金永信投资管理有限公司 | 边兴、 | | | 耀康私募基金(杭州 ) | 有限公司 李家旭、 | | | 个人投资者 | 胡嘉玮、潘海强、陈海威 | | 时间 | 2022 年 8 月 31 日 | 9:30-11:00 | | 地 ...

证券代码：301092 证券简称：争光股份 浙江争光实业股份有限公司 投资者关系活动记录表 编号：2022-004 | --- | --- | --- | |----------------|---------------------------------|------------------------------------------| | | | | | 投资者关系活动 | 特定对象调研 | □分析师会议 | | 类别 | □媒体采访 □业绩说明会 | | | | □新闻发布会 □路演活动 | | | | □现场参观 | | | | □其他（请文字说明其他活动内容） | | | 参与单位名称及 | 长城基金 | 李金洪、储雯玉、陈子扬、陈良栋 | | 人员姓名 | 景顺长城基金 | 陈渤阳、陈莹、张婧 | | | 交银施罗德基金 | 孙婕衎、郭斐、王少成 | | | 南方基金 | 郑勇、张磊、卢玉珊 | | | 安信基金 | 胡双、黄燕、周喆、覃晶晶、朱心怡、郑九洲 | | | 华夏基金 韩霄 | | | | 鹏华基金 王云鹏 | | | | 中融基金 万莉 | | | | 宝盈基金 王灏 | | ...

2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 浙江争光实业股份有限公司 2022 年第三季度报告 证券代码：301092 证券简称：争光股份 公告编号：2022-057 浙江争光实业股份有限公司 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度报告是否经过审计 □是 否 1 浙江争光实业股份有限公司 2022 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 275,136,672.48 | 114.53% | ...

Financial Performance - The company's operating revenue for the first half of 2022 was ¥270,753,001.60, representing a 15.26% increase compared to ¥234,913,827.02 in the same period last year[22]. - The net profit attributable to shareholders was ¥47,767,049.98, a slight increase of 2.04% from ¥46,813,981.31 in the previous year[22]. - The net profit after deducting non-recurring gains and losses was ¥46,465,741.44, which is a 10.49% increase from ¥42,054,584.84 in the same period last year[22]. - Basic and diluted earnings per share were both ¥0.36, reflecting a decrease of 23.40% compared to ¥0.47 in the same period last year[22]. - The weighted average return on equity was 3.05%, down from 11.88% in the previous year, indicating a decline of 8.83%[22]. - The company's operating costs increased by 30.03% to ¥194.25 million, primarily due to rising raw material prices and increased sales[51]. - The company reported a net cash flow from operating activities of approximately ¥23.95 million, a decrease of 12.77% from ¥27.46 million in the previous year[51]. - The company reported a significant increase in investment, with a total investment of ¥1,262,078,037.78, a 715.66% increase compared to the same period last year[60]. - The company reported a total cash outflow from financing activities of ¥55,027,725.74 in the first half of 2022, compared to ¥8,627,953.64 in the same period of 2021, reflecting an increase of 537.5%[173]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,668,575,914.88, a 1.46% increase from ¥1,644,621,182.85 at the end of the previous year[22]. - The net assets attributable to shareholders increased by 2.08% to ¥1,576,458,001.31 from ¥1,544,284,419.74 at the end of the previous year[22]. - Total current assets as of June 30, 2022, are ¥1,454,058,881.93, slightly down from ¥1,491,014,396.25 at the beginning of the year[157]. - The company's total liabilities decreased to CNY 92,117,913.57 from CNY 100,336,763.11, a reduction of 8.1%[159]. - The total liabilities at the end of the reporting period were CNY 2,658 million, reflecting a manageable debt level[187]. Research and Development - The company has a strong focus on R&D, holding 13 valid invention patents as of June 30, 2022, and has applied for 6 new invention patents and 4 utility model patents in 2021[35]. - Research and development investment reached ¥10.22 million, a 4.18% increase from ¥9.81 million in the previous year, reflecting the company's commitment to innovation[51]. - Research and development expenses accounted for 5% of total revenue, emphasizing the commitment to innovation[180]. Market and Industry Position - The company specializes in the research, production, and sales of ion exchange and adsorption resins, covering over 400 models across more than 20 series, with applications in various sectors including industrial water treatment, food and drinking water, nuclear industry, electronics, biomedicine, and environmental protection[32]. - The ion exchange and adsorption resin industry is classified as a strategic emerging industry, with increasing demand driven by the upgrading of industries in emerging countries and regions, as well as the Belt and Road Initiative[30]. - The company has established itself as a leading domestic producer capable of large-scale production of ion exchange and adsorption resins, successfully replacing some imported products[34]. - The downstream demand for ion exchange and adsorption resins is expected to grow, particularly in emerging industries like food and drinking water, nuclear power, and biomedicine, providing significant market opportunities[37]. - The company is recognized as a national high-tech enterprise and plays a key role in setting industry standards, having participated in the formulation of 13 national standards and 3 industry standards[35]. Environmental and Compliance - The company’s wastewater treatment facilities operated normally, meeting all relevant discharge standards during the reporting period[94]. - The company’s air pollution control facilities also operated normally, with all emissions meeting the required standards[94]. - The company strictly adheres to regulations for hazardous waste storage and disposal, ensuring compliance with environmental standards[94]. - The company has implemented a comprehensive emergency response plan for environmental incidents, which was approved by the Ningbo Ecological Environment Bureau[96]. - The company has achieved ISO9001:2015, ISO14001:2015, and ISO45001:2018 certifications for quality, environmental, and occupational health and safety management systems[107]. Shareholder and Governance - The company has a robust governance structure ensuring compliance with laws and regulations, protecting shareholder and creditor rights[104]. - The company has established long-term cooperative relationships with reputable suppliers, ensuring fair contracts and timely payments[107]. - The company has fulfilled all commitments made by actual controllers, shareholders, and related parties during the reporting period[112]. - There were no non-operating fund occupations by controlling shareholders or related parties during the reporting period[114]. - The company did not have any violations regarding external guarantees during the reporting period[115]. Future Outlook - The company plans to expand its market presence, targeting a 10% increase in market share over the next fiscal year[180]. - Future guidance suggests an optimistic outlook with projected revenue growth of 12% for the next half-year[180]. - The company is exploring potential mergers and acquisitions to enhance its competitive edge in the industry[180].

浙江争光实业股份有限公司 2022 年第一季度报告全文 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带 的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声 明：保证季度报告中财务信息的真实、准确、完整。 3.第一季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 证券代码：301092 证券简称：争光股份 公告编号：2022-027 浙江争光实业股份有限公司 2022 年第一季度报告 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入（元） | 129,075,104.49 | 110,185,362.49 | 17.14% | | 归属于上市公司股东的净利润（元） | 19,781,114.86 | 23,974 ...

Financial Performance - The company's operating revenue for 2021 was CNY 451,344,158.90, a decrease of 8.71% compared to CNY 494,417,658.20 in 2020[20] - The net profit attributable to shareholders for 2021 was CNY 73,673,340.64, down 42.18% from CNY 127,426,448.26 in the previous year[20] - The net cash flow from operating activities decreased by 50.86% to CNY 50,327,085.47, compared to CNY 102,419,646.20 in 2020[20] - Basic earnings per share for 2021 were CNY 0.70, a decline of 44.88% from CNY 1.27 in 2020[20] - The total assets at the end of 2021 amounted to CNY 1,644,621,182.85, representing a 234.21% increase from CNY 492,097,000.67 at the end of 2020[20] - The net assets attributable to shareholders increased by 316.38% to CNY 1,544,284,419.74, compared to CNY 370,883,089.09 at the end of 2020[20] - The weighted average return on net assets for 2021 was 12.47%, down 28.99% from 41.46% in 2020[20] - The net profit after deducting non-recurring gains and losses for 2021 was CNY 66,657,635.21, a decrease of 24.85% from CNY 88,699,359.62 in 2020[20] Dividend and Shareholder Information - The company plans to distribute a cash dividend of CNY 1.20 per 10 shares to all shareholders[5] - The total distributable profit for the year was 125,062,181.15 CNY, with cash dividends accounting for 100% of the profit distribution[161] - The cash dividend distribution plan aligns with the company's articles of association and dividend management policies[161] Market Presence and Product Development - The company exports its products to multiple countries including Germany, Switzerland, and the USA, indicating a strong international market presence[34] - The company has achieved various quality certifications including ISO 9001:2015 and WQA Gold Seal Certificate, ensuring high product quality and safety standards[36] - The ion exchange and adsorption resin industry is experiencing increasing demand due to applications in high-end industrial water, food and drinking water, and environmental protection, which may drive future growth for the company[31] - The company is positioned to benefit from the global "carbon neutrality" trend, with its products applicable in carbon capture and recycling of energy metals, aligning with market demands[31] - The main products of the company are ion exchange and adsorption resins, covering over 400 models across 20 series, widely used in various industries including industrial water treatment and biomedicine[37] - The company has established a strong presence in the new energy market, focusing on lithium adsorption materials and purification resins for solar polysilicon, with ongoing R&D efforts[49] Research and Development - The company has 13 invention patents and applied for 6 new invention patents and 4 utility model patents in 2021, showcasing its commitment to research and development[35] - The company invested CNY 17.67 million in R&D, which accounted for 3.91% of total revenue, focusing on new product and process development[64] - The company is developing high-value-added products in the biopharmaceutical sector, including immobilized enzyme carriers and agarose products[51] - The company has established joint R&D centers with universities to accelerate new product development and innovation[58] Operational Efficiency and Cost Management - The company aims to enhance its core competitiveness by improving product quality and reducing environmental pollution for downstream clients[37] - The production process utilizes advanced Distributed Control Systems (DCS) to ensure consistent quality across different batches of products[48] - The company reported a significant reduction of 81.32% in other operating costs, mainly due to the absence of government demolition costs from the previous year[75] - The gross margin for 2021 improved to 35%, up from 30% in 2020, reflecting better cost management and pricing strategies[192] Corporate Governance and Compliance - The company has established a comprehensive internal control system and governance structure, complying with relevant laws and regulations[125] - The board of directors consists of 7 members, including 3 independent directors, ensuring compliance with legal requirements for board composition[126] - The company has a performance evaluation and incentive mechanism in place to ensure fair compensation based on various factors, including job responsibilities and performance[127] - The company emphasizes the importance of accurate, timely, and complete information disclosure to ensure effective communication with investors[128] Environmental Responsibility - The company has implemented pollution prevention facilities during the construction of production projects, ensuring that all wastewater is treated to meet discharge standards before being released into the centralized sewage treatment plant[173] - The company’s wastewater treatment facility operated normally during the reporting period, with all pollutants meeting relevant discharge standards, processing a total of 53.75 tons of COD and 11.2 tons of ammonia nitrogen[173] - The company has developed a self-monitoring plan in accordance with its pollution discharge permit, ensuring monthly reporting of monitoring data[176] Future Outlook - The company provided a positive outlook for 2022, projecting a revenue growth of 15% to 1.725 billion RMB, driven by new product launches and market expansion strategies[194] - New product development efforts include the launch of three innovative products in the next quarter, expected to contribute an additional 200 million RMB in revenue[195] - The company plans to expand its market presence in Southeast Asia, targeting a market share increase of 10% by the end of 2022[196] - A strategic acquisition of a local competitor is anticipated to enhance the company's product offerings and increase market penetration, with an estimated cost of 300 million RMB[197]